aod9604 fat loss clinical trials efficacy side effects mechanism AOD-9604 is the quiet powerhouse your AOD-9604 Safety Profile: What Clinical
Description
Combining these three compounds into one cGMP-made spray format provides researchers with a clean, clearly labeled presentation for multi-pathway investigations involving cellular energy biology, mitochondrial signaling, and metabolic regulation
What they found: Dose-dependent stimulation of type II collagen (up to 2.5 baseline at 100 nM) Stimulation of aggrecan (up to 1.8 baseline) Inhibition of MMP-13 by ~40 % Partial protection against IL-1-induced matrix degradation Why it matters: It opened a completely new research area for AOD-9604 beyond lipolysis
2000 Dec;25(3):287-98
& Vance, D
